Wednesday, February 6, 2019

PACS and RIS Market Analysis & Outlook to 2027 – Siemens AG, Cerner Corporation, IBM Corporation, Allscripts, Agfa-Gevaert Group

The PACS and RIS market is anticipated to grow in the forecast period owing to key factors such as increasing cloud based solutions demand, increased use of cloud-based PACS by large hospitals and diagnostic centers. Moreover, the emerging regional market, and due to a rising awareness and concern for diseases among consumers, the adoption of diagnostic imaging is rapidly increasing, ensuing a generation of amplified imaging data for picture archiving offers opportunities in the growth of the market.
Key players operating in the PACS and RIS market include, McKesson Corporation, General Electric, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Siemens AG, Cerner Corporation, IBM Corporation, Allscripts, Agfa-Gevaert Group, and INFINITT North America Inc. among others.
A cloud-based Picture Archive and Communication System (PACS) solution is an online process to store patient data and digital images. In a cloud-based PACS, patient data files are automatically transferred and stored in the cloud at the time of their creation. Users can access the patient data anywhere, and anytime. PAC system vendor keeps all of the software and hardware at an offsite cloud location. A Radiology Information System (RIS) is a software solution that will help the staff keep better tabs on each patient being treated.
The “Global PACS and RIS Market Analysis to 2027” is a specialized and in-depth study of the healthcare IT industry with a focus on the global market trend. The report aims to provide an overview of global PACS and RIS market with detailed market segmentation by product, component, deployment, end user and geography. The global PACS and RIS market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading PACS and RIS market players and offers key trends and opportunities in the market.
The global PACS and RIS market is segmented on the basis of product, component, deployment and end user. Based on product, the PACS and RIS market is segmented as PACS and RIS. PACS is further sub-segmented into dental PACS, cardiology PACS, oncology PACS, orthopedic PACS, and others. Based on component, the PACS and RIS market is segmented as hardware, software, and services. On the basis of deployment the PACS and RIS market is segmented as web-based, on-premise, and cloud-based. Based on end user, the PACS and RIS market is segmented as hospitals, diagnostic centers, research & academic institutes, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global PACS and RIS market based on product, component, deployment and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PACS and RIS market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the PACS and RIS market in the forecast period, due to presence of large number of PACS companies in the U.S. and favorable government regulations in this region. However, Asia Pacific region is expected to be the fastest growing region owing to the new product launches with broaden applications and growing awareness are expected to accelerate the growth of the market in the region during the forecast period.
The report analyzes factors affecting PACS and RIS market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PACS and RIS market in these regions.
About Us – The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.
Contact Information:
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

6 comments:

  1. LifeVoxel.AI has developed a Interactive Streaming and AI Platform for medical imaging. We own a intellectual property and patent to a new cloud technology platform in medical imaging. At LifeVoxel.AI technology and patents covers secure and highly available cloud storage of medical imaging using supercomputing clusters, advanced 2D and 3D diagnostic visualization of medical images using GPU clusters, and the use of Artificial Intelligence in computer aided detection of medical images using genetic algorithm or convolution nueral networks.

    Interactive Streaming Artificial Intelligence Platform

    ReplyDelete
  2. This comment has been removed by the author.

    ReplyDelete
  3. This comment has been removed by the author.

    ReplyDelete
  4. This comment has been removed by the author.

    ReplyDelete
  5. LifeVoxel.AI platform offers a better alternative for the medical imaging community. Its unique approach is based on 14 international patents that encompass critical patient-centric delivery of care using intuitive, diagnostic and instantly accessible visualizations over the Internet. It works 100X faster and its cheaper by 50%+ than other service providers. We are so honored to be selected by Plug-and-Play from over 120 companies to become the Alliance For Covid-19 (AFC-19) company of choice when it comes to diagnostic imaging software. Our remote 4D and AI inherent capabilities of our patented cloud platform that replaces antiquated on-premises medical imaging systems has made us achieve this important feat.

    RIS PACS Software

    ReplyDelete
  6. Wow! Such an amazing and helpful post this is. I really really love it. It's so good and so awesome. I am just amazed. I hope that you continue to do your work like this in the future also ProspectMedical

    ReplyDelete